Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avalo Therapeutics Inc
(NQ:
AVTX
)
10.13
+0.48 (+4.97%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Avalo Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
November 12, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Avalo Therapeutics to Present at Upcoming Investor Conferences
November 11, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates
November 07, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
October 08, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Avalo Announces Participation in September Investor Conferences
September 04, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
Via
Benzinga
AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q2 2024
August 12, 2024
AVTX stock results show that Avalo Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 12, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
The 3 Best Personalized Nutrition Stocks to Buy Now
July 24, 2024
Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
July 16, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa
July 09, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
June 24, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
June 17, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
AVTX Stock Earnings: Avalo Therapeutics Misses EPS, Beats Revenue for Q4 2023
May 24, 2024
AVTX stock results show that Avalo Therapeutics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q1 2024
May 13, 2024
AVTX stock results show that Avalo Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
May 13, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 29, 2024
Via
Benzinga
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
April 16, 2024
Unlock the potential of Avalo Therapeutics with AVTX-009, a promising drug for hidradenitis suppurativa. Oppenheimer upgrades to Outperform, foreseeing Phase 2 progress and market distinction.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 02, 2024
Via
Benzinga
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 02, 2024
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.
Via
Benzinga
Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
April 02, 2024
Shares of VirTra, Inc. (NASDAQ: VTSI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 02, 2024
It's time to check out all of the biggest pre-market stock movers worth watching on with the winners and losers of Tuesday!
Via
InvestorPlace
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
April 02, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
April 01, 2024
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 01, 2024
It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Avalo Reports 2023 Financial Results and Provides Business Updates
March 29, 2024
From
Avalo Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
March 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 29, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.